Clinical Trials

1,300 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07400835 2026-02-24

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

600 enrolled

Gynecologic

Endometrial Neoplasms

NCT06412029 2026-02-19

HRSN

144 enrolled

Tumor-Agnostic

Neoplasms

NCT04693754 2026-02-18

EUS-RFA

Pancreatic Neoplasms

NCT01382082 2026-02-17

CANTAB

1,432 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04996316 2026-02-13

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

1,141 enrolled

Breast

Breast Neoplasms

NCT07410403 2026-02-13

AI

10 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06730685 2026-02-12

PHILUCA

160 enrolled

Thoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT07274579 2026-02-10

An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

2,000 enrolled

Digestive Oncology

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

25 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT07395505 2026-02-09

PROS-PE

24 enrolled

Rectal Neoplasms

NCT07383298 2026-02-03

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04254133 2026-01-30

GIFTS

1,360 enrolled

Genitourinary

Prostatic Neoplasms

NCT07372261 2026-01-30

PORTENT

1,000 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07373951 2026-01-29

DL-DriverBM

380 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07376681 2026-01-29

Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

2,000 enrolled

Breast

Breast Neoplasms

NCT07362706 2026-01-23

Gastric Cancer

240 enrolled

Stomach Neoplasms, Sleep Apnea, Obstructive

NCT07358208 2026-01-22

PARTNER

3,000 enrolled

Family History of Pancreas Cancer

NCT06472817 2026-01-21

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

80 enrolled

Genitourinary

Prostatic Neoplasms

NCT07346248 2026-01-16

POCAT

266 enrolled

Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery

NCT07347392 2026-01-16

DOSCA-2

2,900 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07132749 2026-01-08

PRO-NEPA

Breast

Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd

NCT05404503 2026-01-06

QuiCo

300 enrolled

Choledochal Cyst, Cholangiocarcinoma

NCT07316075 2026-01-05

Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas